CAMG
NVO

CWA Asset Management Group’s Novo Nordisk NVO Stock Holding History

CWA Asset Management Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
49,879
+374
+0.8% +$16.1K 0.07% 251
2026
Q1 		$1.82M Sell
49,505
-27,488
-36% -$1.3M 0.06% 274
2025
Q4 		$3.92M Buy
76,993
+43,793
+132% +$2.24M 0.14% 141
2025
Q3 		$1.84M Buy
33,200
+29,172
+724% +$1.71M 0.07% 242
2025
Q2 		$278K Sell
4,028
-68,603
-94% -$4.67M 0.01% 552
2025
Q1 		$5.04M Buy
72,631
+40,987
+130% +$3.39M 0.24% 93
2024
Q4 		$2.72M Buy
+31,644
New +$3.42M 0.14% 141

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

CWA Asset Management Group's NVO Position: Q2 2026 in Review

CWA Asset Management Group increased its Novo Nordisk (NVO) stake by 0.76% in Q2 2026, buying an estimated $16.1K and bringing the position to 49,879 shares worth $2.39M. The position accounts for 0.07% of the portfolio, ranked #251.

CWA Asset Management Group first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.04M in Q1 2025. 388 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • CWA Asset Management Group held 49,879 shares of Novo Nordisk worth $2.39M as of Q2 2026.
  • CWA Asset Management Group bought 374 Novo Nordisk shares in Q2 2026, an estimated $16.1K.
  • Novo Nordisk made up 0.07% of CWA Asset Management Group's portfolio in Q2 2026, its #251 holding.
  • CWA Asset Management Group first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • CWA Asset Management Group's Novo Nordisk position peaked at $5.04M in Q1 2025.
  • 388 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.